The recommendation from ECDC follows reports of falsified rabies vaccines and anti-rabies serum circulating in the Philippines and is aimed at travellers who have received the vaccine or serum after possible exposure to rabies.
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.